[go: up one dir, main page]

HRP20120106T1 - Farmaceutski pripravci entakapona koji su mikronizirani zajedno sa šećernim alkoholima - Google Patents

Farmaceutski pripravci entakapona koji su mikronizirani zajedno sa šećernim alkoholima Download PDF

Info

Publication number
HRP20120106T1
HRP20120106T1 HR20120106T HRP20120106T HRP20120106T1 HR P20120106 T1 HRP20120106 T1 HR P20120106T1 HR 20120106 T HR20120106 T HR 20120106T HR P20120106 T HRP20120106 T HR P20120106T HR P20120106 T1 HRP20120106 T1 HR P20120106T1
Authority
HR
Croatia
Prior art keywords
capsule
entacapone
mill
sugar alcohols
following
Prior art date
Application number
HR20120106T
Other languages
English (en)
Croatian (hr)
Inventor
Kapoor Ritesh
Mate Sanjay
Talwar Munish
Kumar Jain Girish
Original Assignee
Wockhardt Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Limited filed Critical Wockhardt Limited
Publication of HRP20120106T1 publication Critical patent/HRP20120106T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20120106T 2008-02-06 2009-02-06 Farmaceutski pripravci entakapona koji su mikronizirani zajedno sa šećernim alkoholima HRP20120106T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN264MU2008 2008-02-06
PCT/IB2009/050490 WO2009098663A1 (en) 2008-02-06 2009-02-06 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols

Publications (1)

Publication Number Publication Date
HRP20120106T1 true HRP20120106T1 (hr) 2012-02-29

Family

ID=40626966

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20120106T HRP20120106T1 (hr) 2008-02-06 2009-02-06 Farmaceutski pripravci entakapona koji su mikronizirani zajedno sa šećernim alkoholima

Country Status (20)

Country Link
US (1) US8728517B2 (es)
EP (1) EP2293791B1 (es)
JP (1) JP5651478B2 (es)
KR (1) KR101532810B1 (es)
CN (1) CN101939002B (es)
AT (1) ATE534382T1 (es)
AU (1) AU2009211030B2 (es)
BR (1) BRPI0907727A2 (es)
CA (1) CA2714113C (es)
CY (1) CY1116484T1 (es)
DK (1) DK2293791T3 (es)
ES (1) ES2377597T3 (es)
HR (1) HRP20120106T1 (es)
MX (1) MX2010008707A (es)
NZ (1) NZ587169A (es)
PL (1) PL2293791T3 (es)
PT (1) PT2293791E (es)
RU (1) RU2010136934A (es)
SI (1) SI2293791T1 (es)
WO (1) WO2009098663A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010023828A1 (de) * 2010-06-15 2011-12-15 IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH Pharmazeutisches Präparat, welches Entacapon, Levodopa und Carbidopa enthält
CN106880607A (zh) * 2015-12-15 2017-06-23 北大方正集团有限公司 一种含有瑞戈非尼的口腔崩解片及其制备方法
CN115715767B (zh) * 2022-11-02 2023-06-09 石家庄四药有限公司 一种恩他卡朋片剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2642486B2 (ja) * 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法
US6599530B2 (en) 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
FI109453B (fi) * 1999-06-30 2002-08-15 Orion Yhtymae Oyj Farmaseuttinen koostumus
WO2006131591A2 (en) * 2005-06-08 2006-12-14 Orion Corporation An entacapone-containing oral dosage form
GB2429645A (en) * 2006-03-10 2007-03-07 Sekhsaria Chemicals Ltd Solid pharmaceutical composition comprising a COMT inhibitor, a starch and a wetting agent

Also Published As

Publication number Publication date
WO2009098663A1 (en) 2009-08-13
DK2293791T3 (da) 2012-02-13
ATE534382T1 (de) 2011-12-15
JP5651478B2 (ja) 2015-01-14
KR20100117096A (ko) 2010-11-02
CY1116484T1 (el) 2017-03-15
CA2714113C (en) 2015-11-24
JP2011526241A (ja) 2011-10-06
US20110052681A1 (en) 2011-03-03
RU2010136934A (ru) 2012-03-20
CN101939002A (zh) 2011-01-05
CA2714113A1 (en) 2009-08-13
AU2009211030A1 (en) 2009-08-13
EP2293791B1 (en) 2011-11-23
SI2293791T1 (sl) 2012-03-30
US8728517B2 (en) 2014-05-20
EP2293791A1 (en) 2011-03-16
BRPI0907727A2 (pt) 2017-06-13
MX2010008707A (es) 2011-03-25
AU2009211030B2 (en) 2013-12-05
NZ587169A (en) 2011-03-31
PL2293791T3 (pl) 2012-04-30
PT2293791E (pt) 2012-01-11
CN101939002B (zh) 2012-12-26
KR101532810B1 (ko) 2015-06-30
ES2377597T3 (es) 2012-03-29

Similar Documents

Publication Publication Date Title
JP4707073B2 (ja) アトルバスタチン経口投与用粒子状医薬組成物
ES2699806T3 (es) Composiciones farmacéuticas, disuasivas del abuso, de liberación inmediata
CN101896167B (zh) 药物组合物
JP2015166379A5 (es)
JP6081436B2 (ja) ヒドロキシアルキルセルロース微粒子
RU2010136935A (ru) Фармацевтические композиции энтакапона, леводопы и карбидопы с улучшенной биодоступностью
EP2647648B1 (en) Solid dosage form containing a low viscosity HYDROXYALKYL CELLULOSE
CN102631347A (zh) 一种吉非替尼药物组合物及其制备方法
WO2013122134A1 (ja) 経口投与用医薬組成物
JP2009502807A5 (es)
JP5367735B2 (ja) 錠剤の製造方法
CA3207801A1 (en) Oily suspensions of microparticulate isotretinoin with improved oral bioavailability
HRP20120106T1 (hr) Farmaceutski pripravci entakapona koji su mikronizirani zajedno sa šećernim alkoholima
RU2012131951A (ru) Фармацевтическая композиция, содержащая частицы реина или диацереина и способ ее получения
JP2009173603A (ja) 漢方薬およびパンテチン類を含有する錠剤
CN102626410A (zh) 一种含有罗氟司特的药物组合物
JP5365949B2 (ja) 低用量ラモセトロン含有口腔内崩壊錠
CN104000821B (zh) 含有替米沙坦和苯磺酸氨氯地平的口服双层片剂及其制备方法
CN111743902A (zh) 一种包含微粉化形式的口服固体药物组合物及其制备方法
CN1895535A (zh) 用于治疗咽喉疾病的中药制剂及其生产方法
CN104027316B (zh) 一种格列美脲片剂及其制备方法
CN105435144A (zh) 一种生姜微丸及其制备方法
JP2013087170A (ja) ヒドロキシプロピルセルロース微粒子
JPWO2014157603A1 (ja) 経口投与用医薬組成物
WO2006101462A3 (en) Pharmaceutical preparation comprising perindopril erbumine and method of preparation and stabilisation thereof